Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Sodium-Glucose Cotransporter (SGLT)-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy

NCT05890131 is registered in ClinicalTrials.gov with Morten Schou as lead sponsor.

NCT NCT05890131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Sodium-Glucose Cotransporter (SGLT)-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy
Lead sponsor
Morten Schou
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2023
Completion date
April 7, 2026
Enrollment
5,996 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure